StockData
AVAIOTCServices-Computer Processing & Data PreparationFiscal year ends March 31

AVAI BIO, INC.

Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.11−0.00 (-1.75%)

Close on Oct 19, 2026

Market cap
$17.24M
P/E (TTM)
–
Dividend yield
–

About Avai Bio

Services-Computer Processing & Data Preparation, SIC 7374

Avai Bio, Inc. develops and commercializes artificial intelligence solutions and provides information technology consulting services. The company focuses on machine learning systems and data integration, database management, and cloud services. Its primary technology assets include Avant! AI, an unsupervised and supervised learning model designed for data processing and reasoning, and Instant Fame, a platform facilitating digital art ratings and auctions. Additionally, the company offers Thy News, a mobile application that aggregates news feeds from various publishers for individual consumers. Through these offerings, Avai Bio serves enterprise organizations seeking artificial intelligence capabilities and end users of its digital media platforms.

The company is incorporated in Nevada and maintains its principal executive offices in Vilnius, Lithuania, alongside an office address in Las Vegas, Nevada. Its operational reach includes a digital content aggregation infrastructure supporting 149,000 processed news sources across mobile application stores.

Summary of the business section of Avai Bio's latest annual report, written by StockData.

Company profile

Company

Legal name
AVAI BIO, INC.
Headquarters
Las Vegas, NV
Address
5348 Vegas Drive 89108
Phone
(866) 533-0065
Employees
1, Mar 31, 2020
Industry
Services-Computer Processing & Data Preparation
Incorporated in
Nevada
Fiscal year ends
March 31
Auditor
Dylan Floyd Accounting & Consulting, Newhall, California

Stock & identifiers

Ticker
AVAI
Exchange
OTC
IPO date
Apr 6, 2020
Shares outstanding
154M, Aug 13, 2026
Public float
$36.85M, Mar 31, 2026
Filer category
Non-accelerated filer<br>Smaller reporting company
Stock splits
20-for-1, Jun 1, 2020
SEC CIK
1740797
EIN
38-4053064

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

No recent ownership filings by officers or directors

Avai Bio's leadership is listed in its proxy statement (Form DEF 14A).

Employees

Headcount reported in annual reports

“We currently have one employee only - Natalija Tunevic, our president, treasurer, secretary and director.”

Corporate history

Events identified from SEC filings

DateEventDetails
Jun 30, 2026Late filingNotification of late filing
Feb 9, 2026Name changeName changed from AVANT TECHNOLOGIES INC. to AVAI BIO, INC.
Jun 30, 2025Late filingNotification of late filing
Aug 14, 2024Late filingNotification of late filing
Jul 2, 2024Late filingNotification of late filing
Apr 8, 2024Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Nov 14, 2023Late filingNotification of late filing
Aug 15, 2023Late filingNotification of late filing
Jul 19, 2023Name changeName changed from TREND INNOVATIONS HOLDING INC. to AVANT TECHNOLOGIES INC.
Jun 30, 2023Late filingNotification of late filing
Aug 15, 2022Late filingNotification of late filing
Aug 16, 2021Late filingNotification of late filing
Jun 29, 2021Late filingNotification of late filing
Feb 16, 2021Late filingNotification of late filing
Aug 14, 2020Late filingNotification of late filing
Jun 5, 2020Name changeName changed from FREECOOK to TREND INNOVATIONS HOLDING INC.
Sep 18, 2019Auditor changeChange in certifying accountant (8-K Item 4.01)
Sep 10, 2019Auditor changeChange in certifying accountant (8-K Item 4.01)
Aug 14, 2019Late filingNotification of late filing
Jul 1, 2019Late filingNotification of late filing